Clinical Trial Update: Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 study of ISIS 703802 in participants with hypertriglyceridemia, type 2 diabetes, and nonalcoholic fatty liver disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• ISIS 703802

Snippet

Sponsor: Akcea Therapeutics | Conditions: NAFLD, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2021-02-01